Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Isaac Teitelbaum

Concepts (357)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peritoneal Dialysis
56
2025
97
14.370
 Why?
Kidney Failure, Chronic
42
2025
565
7.860
 Why?
Peritonitis
22
2025
84
4.650
 Why?
Renal Dialysis
18
2022
434
2.420
 Why?
Dialysis Solutions
11
2023
21
1.780
 Why?
Peritoneum
6
2023
43
1.160
 Why?
Kidney
8
2023
1472
1.140
 Why?
Sodium
3
2025
218
0.980
 Why?
Hyponatremia
2
2025
42
0.950
 Why?
Serum Albumin
3
2022
150
0.880
 Why?
Kidney Tubules, Collecting
12
1994
31
0.870
 Why?
Catheters, Indwelling
5
2019
83
0.720
 Why?
Peritoneal Dialysis, Continuous Ambulatory
6
2021
15
0.720
 Why?
Acute Kidney Injury
5
2023
811
0.660
 Why?
Staphylococcus capitis
1
2019
1
0.660
 Why?
Coagulase
1
2019
6
0.650
 Why?
Renal Insufficiency, Chronic
3
2015
616
0.620
 Why?
Renal Replacement Therapy
4
2023
92
0.620
 Why?
Ferric Compounds
2
2022
55
0.610
 Why?
Catheter-Related Infections
1
2019
80
0.600
 Why?
Sucrose
2
2022
109
0.600
 Why?
Quality of Health Care
2
2020
627
0.600
 Why?
Arginine Vasopressin
7
1997
43
0.560
 Why?
Anti-Bacterial Agents
6
2024
1800
0.560
 Why?
Hyperphosphatemia
3
2022
15
0.560
 Why?
Kidney Transplantation
3
2012
701
0.550
 Why?
Humans
78
2025
137514
0.540
 Why?
Peritoneal Fibrosis
1
2017
1
0.540
 Why?
Staphylococcal Infections
3
2019
402
0.530
 Why?
Kidney Function Tests
4
2020
158
0.520
 Why?
Uremia
2
2014
16
0.510
 Why?
Glucans
2
2015
36
0.500
 Why?
Patient-Centered Care
1
2020
527
0.480
 Why?
Therapeutics
1
2015
14
0.470
 Why?
Body Water
1
2015
21
0.460
 Why?
Kidney Medulla
10
1997
35
0.460
 Why?
Voriconazole
1
2015
20
0.460
 Why?
beta-Cyclodextrins
1
2015
30
0.460
 Why?
Phosphates
2
2022
184
0.440
 Why?
Catheterization
3
2016
179
0.440
 Why?
Antifungal Agents
1
2015
137
0.440
 Why?
Chelating Agents
1
2014
75
0.420
 Why?
Blood Pressure
1
2020
1776
0.410
 Why?
GTP-Binding Proteins
6
1995
163
0.390
 Why?
Hemodialysis Solutions
1
2012
3
0.390
 Why?
Type C Phospholipases
6
1992
75
0.390
 Why?
Acidosis
1
2013
101
0.370
 Why?
Kidney Diseases
4
2021
407
0.370
 Why?
Hemofiltration
2
2010
30
0.360
 Why?
Glucose
2
2015
1018
0.340
 Why?
Hirudins
1
2010
53
0.340
 Why?
Urea
4
2021
81
0.320
 Why?
Cyclic AMP
6
1995
243
0.320
 Why?
Creatinine
5
2020
501
0.310
 Why?
Protein Kinase C
5
1995
265
0.310
 Why?
Kidney Tubules
4
1990
117
0.310
 Why?
Heparin
1
2010
259
0.310
 Why?
Nutritional Status
4
2022
344
0.300
 Why?
Heart Diseases
1
2012
359
0.290
 Why?
Glomerular Filtration Rate
5
2023
746
0.290
 Why?
Drug Resistance, Bacterial
1
2009
183
0.290
 Why?
Hemodialysis, Home
4
2023
8
0.280
 Why?
Middle Aged
19
2025
33355
0.260
 Why?
Peptide Fragments
1
2010
708
0.260
 Why?
Survivors
1
2010
489
0.260
 Why?
Cardiac Surgical Procedures
1
2012
531
0.250
 Why?
Scleroderma, Systemic
1
2007
122
0.250
 Why?
Patient Selection
2
2020
691
0.250
 Why?
Calcium
4
2020
1233
0.240
 Why?
Hernia, Abdominal
1
2005
7
0.240
 Why?
Postoperative Complications
3
2012
2641
0.240
 Why?
Peritoneal Cavity
1
2005
31
0.240
 Why?
Patient Participation
2
2020
423
0.230
 Why?
Prospective Studies
11
2023
7598
0.230
 Why?
Phosphorus
3
2022
97
0.230
 Why?
Liver Failure
1
2005
94
0.220
 Why?
Time Factors
6
2015
6817
0.220
 Why?
Internationality
3
2020
155
0.220
 Why?
Hemoglobins
2
2020
356
0.220
 Why?
Aged
14
2025
23798
0.220
 Why?
Liver Transplantation
2
2012
872
0.220
 Why?
Teicoplanin
1
2024
15
0.210
 Why?
Practice Patterns, Physicians'
2
2025
1312
0.210
 Why?
Quality Improvement
2
2023
1161
0.210
 Why?
Male
24
2025
67718
0.210
 Why?
Blood Chemical Analysis
1
2003
98
0.200
 Why?
Quality of Life
5
2020
2870
0.200
 Why?
Practice Guidelines as Topic
3
2020
1580
0.190
 Why?
Device Removal
2
2019
138
0.190
 Why?
Female
23
2025
73162
0.190
 Why?
Phosphatidylinositols
3
1991
57
0.190
 Why?
Rats
13
2014
5676
0.190
 Why?
Contraindications, Procedure
1
2021
11
0.190
 Why?
Goals
2
2020
168
0.190
 Why?
Nephrologists
1
2021
12
0.180
 Why?
Attitude of Health Personnel
2
2020
1169
0.180
 Why?
Organism Hydration Status
1
2020
10
0.180
 Why?
Critical Illness
4
2023
809
0.170
 Why?
Superior Vena Cava Syndrome
1
2000
3
0.170
 Why?
Chylous Ascites
1
2000
6
0.170
 Why?
Epidermal Growth Factor
6
1994
174
0.170
 Why?
Acid-Base Equilibrium
1
2020
28
0.170
 Why?
Liver Cirrhosis
1
2003
316
0.170
 Why?
Risk Factors
7
2023
10356
0.170
 Why?
Stress, Psychological
1
2009
1115
0.170
 Why?
Treatment Outcome
9
2020
10821
0.170
 Why?
Blood Volume
1
2020
61
0.170
 Why?
Patient Care Planning
1
2020
155
0.160
 Why?
Magnesium
1
2020
159
0.160
 Why?
Potassium
1
2020
151
0.160
 Why?
Cohort Studies
5
2025
5730
0.160
 Why?
Patient Reported Outcome Measures
2
2020
403
0.160
 Why?
Physician Executives
1
2019
32
0.160
 Why?
Congresses as Topic
1
2020
233
0.140
 Why?
Dogs
2
2023
411
0.140
 Why?
Drug Combinations
2
2022
344
0.140
 Why?
Societies, Medical
2
2020
820
0.140
 Why?
Survival Rate
2
2020
1980
0.140
 Why?
Receptors, Vasopressin
2
1995
20
0.140
 Why?
Kidney Concentrating Ability
1
1997
3
0.140
 Why?
Renal Insufficiency
1
2020
157
0.140
 Why?
Patient Education as Topic
3
2018
766
0.140
 Why?
Adenylyl Cyclase Inhibitors
2
1994
8
0.140
 Why?
Data Collection
1
2020
674
0.140
 Why?
Risk Assessment
4
2016
3439
0.140
 Why?
Adenylyl Cyclases
3
1993
87
0.130
 Why?
Adult
18
2024
37821
0.130
 Why?
United States
7
2023
14696
0.130
 Why?
Proportional Hazards Models
3
2022
1263
0.130
 Why?
Survival Analysis
2
2015
1320
0.120
 Why?
Hormones
2
1994
143
0.120
 Why?
Models, Animal
1
2017
387
0.120
 Why?
Ultrafiltration
1
2015
28
0.120
 Why?
Epithelial-Mesenchymal Transition
1
2017
212
0.110
 Why?
Curriculum
1
2021
980
0.110
 Why?
Kaplan-Meier Estimate
2
2015
892
0.110
 Why?
Gastrointestinal Absorption
1
2014
5
0.110
 Why?
Lung Injury
1
2017
218
0.110
 Why?
Palliative Care
1
2020
738
0.110
 Why?
Diglycerides
2
1993
61
0.110
 Why?
Inflammation
3
2017
2837
0.110
 Why?
Virulence Factors, Bordetella
2
1991
20
0.110
 Why?
Pertussis Toxin
2
1991
26
0.110
 Why?
Treatment Failure
1
2015
353
0.110
 Why?
Didanosine
1
1993
13
0.110
 Why?
Biological Transport
1
2015
416
0.110
 Why?
Phospholipases A
2
1992
102
0.110
 Why?
Anti-Infective Agents
1
2016
256
0.100
 Why?
Cytosol
1
1994
227
0.100
 Why?
Animals
17
2023
37011
0.100
 Why?
Biomedical Research
1
2020
689
0.100
 Why?
HIV Seropositivity
1
1993
124
0.100
 Why?
Oleanolic Acid
1
2012
9
0.100
 Why?
Methylene Blue
1
2012
23
0.100
 Why?
Equipment Design
2
2014
526
0.100
 Why?
Tissue Adhesions
1
2012
32
0.100
 Why?
Vascular Calcification
1
2014
109
0.100
 Why?
Delayed Graft Function
1
2012
33
0.090
 Why?
Hematinics
1
2012
22
0.090
 Why?
Prognosis
4
2016
4031
0.090
 Why?
Cells, Cultured
9
1994
4206
0.090
 Why?
Receptors, Angiotensin
1
1991
12
0.090
 Why?
Vasoconstrictor Agents
1
2012
138
0.090
 Why?
Nephrectomy
1
2012
168
0.090
 Why?
Transplantation, Homologous
1
2012
416
0.090
 Why?
Atrial Natriuretic Factor
1
1991
56
0.090
 Why?
Hypotension
1
2012
123
0.090
 Why?
Restless Legs Syndrome
1
2011
22
0.090
 Why?
Retrospective Studies
6
2023
15628
0.090
 Why?
Bacterial Infections
2
2003
251
0.090
 Why?
Glycerides
1
1990
21
0.080
 Why?
Aluminum Compounds
1
1990
6
0.080
 Why?
Phospholipases
1
1990
14
0.080
 Why?
Antithrombins
1
2010
59
0.080
 Why?
Membranes, Artificial
1
2010
72
0.080
 Why?
Follow-Up Studies
4
2011
5139
0.080
 Why?
Virginiamycin
1
2009
3
0.080
 Why?
Linezolid
1
2009
20
0.080
 Why?
Models, Biological
1
2017
1775
0.080
 Why?
Daptomycin
1
2009
19
0.080
 Why?
Oxazolidinones
1
2009
15
0.080
 Why?
Graft Survival
1
2012
540
0.080
 Why?
Double-Blind Method
2
2012
1987
0.080
 Why?
Minerals
1
2009
42
0.080
 Why?
Acetamides
1
2009
36
0.080
 Why?
Protein Kinases
1
1991
319
0.080
 Why?
Infection Control
1
2010
158
0.070
 Why?
Enzyme Inhibitors
1
2012
845
0.070
 Why?
Antibiotic Prophylaxis
2
2022
117
0.070
 Why?
Hematuria
1
1988
12
0.070
 Why?
Communicable Diseases
1
2010
160
0.070
 Why?
Sympathetic Nervous System
1
1989
181
0.070
 Why?
Enzyme Activation
4
1994
816
0.070
 Why?
Kidney Tubular Necrosis, Acute
1
2007
26
0.070
 Why?
Hepatorenal Syndrome
1
2007
16
0.070
 Why?
Proteinuria
1
1988
98
0.070
 Why?
Aged, 80 and over
1
2019
7593
0.070
 Why?
Sleep Wake Disorders
1
2011
283
0.070
 Why?
Tetradecanoylphorbol Acetate
3
1993
151
0.070
 Why?
Spondylitis, Ankylosing
1
1988
46
0.070
 Why?
Recombinant Proteins
1
2010
1357
0.070
 Why?
RNA, Messenger
1
1995
2838
0.070
 Why?
Primary Prevention
2
2016
197
0.070
 Why?
Inositol Phosphates
3
1991
23
0.070
 Why?
ErbB Receptors
1
1990
616
0.060
 Why?
Biopsy, Needle
1
2007
191
0.060
 Why?
Anticoagulants
1
2010
665
0.060
 Why?
Hemodialysis Units, Hospital
1
2005
5
0.060
 Why?
Nephrology
2
2020
61
0.060
 Why?
Incidence
3
2007
2792
0.060
 Why?
Imipenem
1
2005
18
0.060
 Why?
Ethics, Clinical
1
2005
7
0.060
 Why?
Medication Adherence
1
2009
471
0.060
 Why?
Kinetics
3
2017
1679
0.060
 Why?
Skin Diseases
1
2007
149
0.060
 Why?
Vasculitis
1
2005
65
0.060
 Why?
Capillaries
1
2005
108
0.060
 Why?
Staphylococcus aureus
1
2009
452
0.060
 Why?
Fibrosis
1
2007
552
0.050
 Why?
Gastric Acid
1
2023
14
0.050
 Why?
Canada
1
2005
421
0.050
 Why?
Bromcresol Green
1
2003
1
0.050
 Why?
Bromcresol Purple
1
2003
1
0.050
 Why?
Health Services Accessibility
1
2011
976
0.050
 Why?
Nephelometry and Turbidimetry
1
2003
13
0.050
 Why?
Hepcidins
1
2023
22
0.050
 Why?
Combined Modality Therapy
1
2007
1241
0.050
 Why?
Indicators and Reagents
1
2003
109
0.050
 Why?
Permeability
1
2003
162
0.050
 Why?
Triglycerides
1
2006
525
0.050
 Why?
Equipment Failure
1
2003
108
0.050
 Why?
Drug Resistance
2
2012
170
0.050
 Why?
Disease Models, Animal
1
2014
4295
0.050
 Why?
Eosinophils
1
2006
331
0.050
 Why?
Vancomycin
1
2024
84
0.050
 Why?
Inositol 1,4,5-Trisphosphate
2
1994
31
0.050
 Why?
Severity of Illness Index
2
2011
2838
0.050
 Why?
Monocytes
1
2006
568
0.050
 Why?
Regression Analysis
1
2005
1029
0.050
 Why?
Medicare
2
2022
747
0.050
 Why?
Cats
1
2023
211
0.050
 Why?
Burns
1
2007
323
0.050
 Why?
Hypoalbuminemia
1
2022
31
0.050
 Why?
Lung Transplantation
1
2005
309
0.050
 Why?
Ownership
1
2023
91
0.050
 Why?
Phospholipases A2
2
1992
80
0.050
 Why?
Patient Compliance
1
2006
586
0.050
 Why?
Positron-Emission Tomography
1
2023
299
0.040
 Why?
Guanosine 5'-O-(3-Thiotriphosphate)
2
1991
15
0.040
 Why?
Guanosine Diphosphate
2
1991
21
0.040
 Why?
Thionucleotides
2
1991
36
0.040
 Why?
Erythrocytes
1
2006
693
0.040
 Why?
Dinoprostone
2
1990
191
0.040
 Why?
Recurrence
1
2003
1060
0.040
 Why?
Chronic Disease
1
2005
1790
0.040
 Why?
Terminology as Topic
1
2020
216
0.040
 Why?
Child
3
2013
22037
0.040
 Why?
Potassium, Dietary
1
1998
12
0.040
 Why?
Drinking
1
1998
42
0.040
 Why?
Predictive Value of Tests
2
2017
2039
0.040
 Why?
Sodium, Dietary
1
1998
41
0.040
 Why?
Diabetes Mellitus, Type 2
1
2012
2521
0.030
 Why?
Cardiovascular Diseases
1
2010
2113
0.030
 Why?
Diabetic Nephropathies
1
2000
293
0.030
 Why?
Pilot Projects
1
2022
1703
0.030
 Why?
Quality Control
1
2017
171
0.030
 Why?
Dose-Response Relationship, Drug
2
1991
2066
0.030
 Why?
Fluid Therapy
1
2017
147
0.030
 Why?
Hospitalization
1
2006
2197
0.030
 Why?
Reproducibility of Results
1
2003
3292
0.030
 Why?
Prostaglandins
1
1995
97
0.030
 Why?
Ionomycin
1
1994
25
0.030
 Why?
Quality Indicators, Health Care
1
2017
310
0.030
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1994
182
0.030
 Why?
Isoproterenol
1
1994
116
0.030
 Why?
Colforsin
1
1993
54
0.030
 Why?
Prevalence
2
2011
2719
0.030
 Why?
Guanylate Cyclase
1
1992
37
0.030
 Why?
Shock, Surgical
1
2012
2
0.020
 Why?
Interleukin-6
1
2017
778
0.020
 Why?
Intraoperative Care
1
2012
49
0.020
 Why?
Catecholamines
1
2012
98
0.020
 Why?
Sample Size
1
2012
118
0.020
 Why?
Poisson Distribution
1
2012
75
0.020
 Why?
Prospective Payment System
1
2011
13
0.020
 Why?
Total Quality Management
1
2011
60
0.020
 Why?
Base Sequence
1
1995
2180
0.020
 Why?
Inositol
1
1991
26
0.020
 Why?
Accreditation
1
2011
84
0.020
 Why?
Receptors, Oxytocin
1
1991
24
0.020
 Why?
Cyclic GMP
1
1991
94
0.020
 Why?
Dideoxyadenosine
1
1990
3
0.020
 Why?
Oxytocin
1
1991
52
0.020
 Why?
Molecular Sequence Data
1
1995
2901
0.020
 Why?
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
1
1990
28
0.020
 Why?
Adenosine Diphosphate Ribose
1
1990
7
0.020
 Why?
Isoquinolines
1
1990
44
0.020
 Why?
Fluorides
1
1990
50
0.020
 Why?
Guanosine Triphosphate
1
1990
92
0.020
 Why?
Aluminum
1
1990
42
0.020
 Why?
Hydrolysis
1
1990
191
0.020
 Why?
Rats, Sprague-Dawley
1
1995
2501
0.020
 Why?
Adrenergic alpha-Agonists
1
1989
30
0.020
 Why?
Adrenergic alpha-Antagonists
1
1989
34
0.020
 Why?
Analysis of Variance
1
2012
1324
0.020
 Why?
Health Surveys
1
2011
520
0.020
 Why?
Rats, Inbred Strains
1
1989
369
0.020
 Why?
In Vitro Techniques
1
1990
1108
0.020
 Why?
Adrenergic beta-Agonists
1
1989
133
0.020
 Why?
Glomerulonephritis, IGA
1
1988
11
0.020
 Why?
Piperazines
1
1990
351
0.020
 Why?
Clinical Trials as Topic
1
2012
1047
0.020
 Why?
Cost of Illness
1
2009
304
0.020
 Why?
Adrenergic beta-Antagonists
1
1989
324
0.020
 Why?
Morbidity
1
2007
322
0.020
 Why?
Research Design
1
2012
1116
0.020
 Why?
Cilastatin
1
2005
2
0.020
 Why?
Hemodiafiltration
1
2005
9
0.020
 Why?
Biomarkers
1
2017
4172
0.010
 Why?
Multivariate Analysis
1
2009
1524
0.010
 Why?
Healthcare Disparities
1
2012
651
0.010
 Why?
Osmolar Concentration
2
1998
174
0.010
 Why?
Telemedicine
1
2014
852
0.010
 Why?
Protease Inhibitors
1
2005
107
0.010
 Why?
Sensitivity and Specificity
1
2009
1950
0.010
 Why?
Biopsy
1
1988
1132
0.010
 Why?
Comorbidity
1
2009
1618
0.010
 Why?
Protein Kinase Inhibitors
1
1990
920
0.010
 Why?
Acute Disease
1
2007
1008
0.010
 Why?
Respiratory Function Tests
1
2005
596
0.010
 Why?
Drug Therapy, Combination
1
2005
1060
0.010
 Why?
Graft Rejection
1
2005
623
0.010
 Why?
Immunosuppressive Agents
1
2005
891
0.010
 Why?
Colorado
1
1990
4521
0.010
 Why?
Mice
1
2017
17843
0.010
 Why?
Lung Diseases
1
2005
768
0.010
 Why?
Diet, Vegetarian
1
1998
8
0.010
 Why?
Beer
1
1998
12
0.010
 Why?
Urine
1
1998
61
0.010
 Why?
Cross-Sectional Studies
1
2009
5427
0.010
 Why?
Dietary Proteins
1
1998
135
0.010
 Why?
Signal Transduction
1
1990
5096
0.010
 Why?
Muscarine
1
1994
3
0.010
 Why?
Carbachol
1
1994
20
0.010
 Why?
Vasopressins
1
1994
64
0.010
 Why?
Tyrosine
1
1994
224
0.010
 Why?
Cell Polarity
1
1994
141
0.010
 Why?
Purines
1
1994
176
0.010
 Why?
Adolescent
1
2012
21555
0.010
 Why?
Lung
1
2005
4066
0.010
 Why?
Hypertonic Solutions
1
1991
7
0.010
 Why?
Nocodazole
1
1991
16
0.010
 Why?
Cycloheximide
1
1991
55
0.010
 Why?
Isotonic Solutions
1
1991
38
0.010
 Why?
Culture Media
1
1991
167
0.010
 Why?
Phosphorylation
1
1994
1762
0.010
 Why?
Peptides
1
1994
986
0.000
 Why?
Teitelbaum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (357) concept(s)
_
Co-Authors Expand Description
See all (21) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)